Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Braces For Impact: Advair Generic Could Reduce US Brand To £1Bn

Related Content

Teva AirDuo Poised To Be A Discounted, But Not Interchangeable, Version Of Advair

Jan 30 2017

GSK US Pharma President Jack Bailey On A “Dynamic” 2017

Jan 23 2017

Advair: A Big Generic Opportunity And A Big Question Mark In 2017

Dec 29 2016

Related Companies

GSK plc

Viatris Inc.

Hikma Pharmaceuticals plc

Teva Pharmaceutical Industries Ltd.

Novartis AG

AstraZeneca PLC

Additional Topics

Sales & Earnings Business Strategies Generic Drugs Commercial Respiratory BioPharmaceutical

More from Earnings

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window